Primary Care Clinics in Knoxville, IA Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Planned Parenthood Of The Heartland Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 909 W Pleasant Street, Knoxville, IA 50138 Phone: 866-290-4325 Fax: 515-280-9525 |
Knoxville Hospital & Clinics Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1202 W Howard St, Knoxville, IA 50138 Phone: 641-828-7211 Fax: 641-842-7030 |
Community Health Centers Of Southern Iowa, Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 1504 N Lincoln St, Knoxville, IA 50138 Phone: 641-828-6208 |
News Archive
Dysport, an anti-wrinkle alternative to Botox
The new anti-wrinkle facial filler Dysport, which could be used as an alternative to Botox, noticeably reduced frown lines between the eyes, according to users and independent reviewers in a study involving plastic surgeons at UT Southwestern Medical Center.
New trial tests surgery for Type 2 diabetes
A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.
New treatment for Tourette Syndrome, patients experience significant resolution of symptoms following brain surgery
A neurosurgical team at University Hospitals of Cleveland (UHC) has, for the first time in North America, applied a new surgical approach to the treatment of Tourette syndrome, resulting in the immediate and nearly complete resolution of symptoms for the patient, who has suffered from this neurologic disorder since he was a child.
FDA approves HEMLIBRA for treatment of hemophilia A
Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.
Nanoparticles in cosmetics may be harmful to the environment
Using aquatic microbes as their "canary-in-a-cage," scientists from Ohio have reported that nanoparticles now being added to cosmetics, sunscreens, and hundreds of other personal care products may be harmful to the environment.
› Verified 6 days ago